Assay performance and stability of uracil and dihydrouracil in clinical practice by Knikman, Jonathan E., Rosing, Hilde, Guchelaar, Henk-Jan, Cats, Annemieke, Beijnen, Jos H.

Get full text

Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options? by Knikman, Jonathan E., Gelderblom, Hans, Beijnen, Jos H., Cats, Annemieke, Guchelaar, Henk‐Jan, Henricks, Linda M.

Get full text

A Nomogram to Predict Severe Toxicity in DPYD Wild‐Type Patients Treated With Capecitabine‐Based Anticancer Regimens by Knikman, Jonathan E., Lopez‐Yurda, Marta, Meulendijks, Didier, Deenen, Maarten J., Schellens, Jan H.M., Beijnen, Jos, Cats, Annemieke, Guchelaar, Henk‐Jan

Get full text

A review of the bioanalytical methods for the quantitative determination of capecitabine and its metabolites in biological matrices by Knikman, Jonathan E., Rosing, Hilde, Guchelaar, Henk‐Jan, Cats, A., Beijnen, Jos H.

Get full text

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study by With, Mirjam, Knikman, Jonathan, Man, Femke M., Lunenburg, Carin A. T. C., Henricks, Linda M., Kuilenburg, André B. P., Maring, Jan G., Staveren, Maurice C., Vries, Niels, Rosing, Hilde, Beijnen, Jos H., Pluim, Dick, Modak, Anil, Imholz, Alex L. T., Schaik, Ron H. N., Schellens, Jan H. M., Gelderblom, Hans, Cats, Annemieke, Guchelaar, Henk‐Jan, Mathijssen, Ron H. J., Swen, Jesse J., Meulendijks, Didier

Get full text

Response to “Plasma Uracil as a DPD Phenotyping Test: Pre‐analytical Handling Matters” by With, Mirjam, Knikman, Jonathan, Schellens, Jan H. M., Gelderblom, Hans, Cats, Annemieke, Guchelaar, Henk‐Jan, Mathijssen, Ron H. J., Swen, Jesse J., Meulendijks, Didier

Get full text